Crocky! Bloody worried about Osiris intellectual property?
I was too mate, until I read this back in February!
She's a beauty and pass the Vegemite!
Feb 19, 2013
US-based Osiris Therapeutics, which develops and markets stem cell products to treat serious medical conditions, has won a patent challenge in Australia by an opponent whose identity under the law was not disclosed. The patent at issue covers the administration of mesenchymal stem cells (MSCs), including Prochymal (remestemcel-L), for the treatment of inflammatory conditions involving the gastrointestinal tract, including Crohn's disease and ulcerative colitis. Prochymal is the world's first approved drug with a stem cell as its active ingredient. Developed by Osiris Therapeutics, Prochymal is an intravenous formulation of MSCs, which are derived from the bone marrow of healthy adult donors between the ages of 18 and 30 years. As acknowledged in the Australian Official Journal of Patents Supplement, all claims to the patent will be maintained in full. The claims specifically include the use of allogeneic MSCs, an attribute central to making an off-the-shelf MSC product possible.
Can't you hear can't http://www.youtube.com/watch?v=As6s4Vt_3uw you hear that thunder! He just smiled and handed me a Vegemite sandwich! Next stop for Prochymal is a land down under. Because New Zealand approved and they soon will consolidate all pharma approvals.
Sci, you are one of the very astute investors that I was referring to. Yes, I am well aware of the recent Osiris legal win I presume over Mesoblast. And I also believe that Australia will also approve Prochymal in the very near future. A few nights ago I had dinner with a powerful Australian stock broker who plays tennis with Mesoblasts CEO. He was unaware of this patent and intellectual property infringement. Osiris's primary assets are it's patents and intellectual property rights. I just want to make sure that they are very strong and bulletproof.